SPOTLIGHT -
EP. 1: Advancements in Treatment and Management of HER2-Positive Early Breast Cancer: Introduction and the APHINITY Trial
Watch
EP. 2: Disease-Free Survival and the KATHERINE Study
EP. 3: Review of the ExteNET Trial and the TRAIN-2 Trial
EP. 4: Agents or Regimens Moving from Metastatic to Early Stage
EP. 5: Role of Biosimilars in Breast Cancer
EP. 6: Subcutaneous Combination Therapy With the FeDeriCa Study
EP. 7: Comparison of IV vs SQ Dosing and Patient Factors
EP. 8: Barriers for Novel Agents
EP. 9: Pharmacists’ Role for Transitioning from IV to SQ
EP. 10: Telehealth During COVID-19 Pandemic
EP. 11: Influence of SQ and COVID-19 on Therapy
EP. 12: Future Therapies in Breast Cancer and Final Thoughts
